Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Euronext Bruxelles  >  Agfa-Gevaert    AGFB   BE0003755692

SummaryQuotesChartsNewsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets 

AGFA-GEVAERT : Annual General Meeting of Agfa-Gevaert

share with twitter share with LinkedIn share with facebook
share via e-mail
0
04/24/2012 | 02:31pm CET
  • Press Release
  • Mortsel (Belgium)
  • April 24, 2012 02:00

At Agfa-Gevaert's Annual General Meeting today, all the voting points on the agenda were approved. These included the approval of the 2011 financial statements, the allocation of the result as well as the discharge of directors and auditors.

The shareholders also approved the reappointment of De Wilde J Management BVBA, with permanent representative Julien De Wilde, and Christian Leysen as members of the Board of Directors. Finally, the General Meeting resolved, in accordance with article 556 of the Companies Code, to approve the change-of-control provisions, as stipulated in the Facility Agreement dated May 31, 2011 with Fortis Bank SA/NV, ING Belgium SA/NV and KBC Bank NV on the one hand and Agfa HealthCare NV, Agfa Graphics NV and Agfa-Gevaert NV on the other hand.

At the consequent Extraordinary General Meeting today - all the voting points on the agenda, all of them regarding changes in the articles of association - were approved, except for voting point n°3 regarding the spread in time of the variable remuneration.


Viviane Dictus
Director Corporate Communication
Septestraat 27
2640 Mortsel - Belgium
tel+32 (0) 3 444 7124
fax+32 (0) 3 444 4485
viviane.dictus@agfa.com
Johan Jacobs
Corporate Press Relations Manager
Septestraat 27
2640 Mortsel - Belgium
tel+32 (0) 3 444 8015
fax+32 (0) 3 444 4485
johan.jacobs@agfa.com
distributed by
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on AGFA-GEVAERT
03/23 AGFA GEVAERT : Publication of a transparency notification - Regulated informatio..
03/23 AGFA-GEVAERT : Publication of a transparency notification - Regulated informatio..
03/22 AGFA-GEVAERT : Publication of a transparency notification - Regulated informatio..
03/22 AGFA GEVAERT : Publication of a transparency notification – Regulated info..
03/14 FUJIFILM : Leycol Print signs three-year plate deal with Fujifilm
03/09 AGFA GEVAERT : Graphics Puts Spotlight on Brand Reputation
03/08 AGFA GEVAERT : publishes its full year 2016 results - regulated information
03/08 AGFA-GEVAERT PUBLISHES ITS FULL YEAR : 45 a.m. CET
03/02 XEROX : Patent Issued for Movable Vacuum Divider (USPTO 9573393)
02/28 AGFA GEVAERT : Petroleum Engineers Seek Gas Terms for Deep Offshore
More news
Sector news : Advanced Medical Equipment & Technology - NEC
02/09 Infineon, Cree warn U.S. might block Wolfspeed deal
02/02 EU probes online sales in electronics, video games, hotels
01/31DJTHERMO FISHER SCIENTIFIC : Earnings, Sales Rise
01/31DJDANAHER : Revenue, Profit Rise
01/30DJEUROPEAN MORNING BRIEFING : Corporate Events
More sector news : Advanced Medical Equipment & Technology - NEC
News from SeekingAlpha
03/08 Agfa-Gavaert's (AFGVF) CEO Christian Reinaudo on Q4 2016 Results - Earnings C..
03/08 Agfa-Gavaert NV reports Q4 results
03/08 Agfa-Gavaert NV 2016 Q4 - Results - Earnings Call Slides
2016 Agfa-Gavaert's (AFGVF) CEO Christian Reinaudo on Q1 2017 Results - Earnings C..
2016 Agfa-Gavaert NV 2016 Q3 - Results - Earnings Call Slides
Advertisement
Financials (€)
Sales 2017 2 504 M
EBIT 2017 159 M
Net income 2017 81,0 M
Finance 2017 192 M
Yield 2017 -
P/E ratio 2017 8,20
P/E ratio 2018 9,03
EV / Sales 2017 0,23x
EV / Sales 2018 0,22x
Capitalization 761 M
More Financials
Chart AGFA-GEVAERT
Duration : Period :
Agfa-Gevaert Technical Analysis Chart | AGFB | BE0003755692 | 4-Traders
Full-screen chart
Technical analysis trends AGFA-GEVAERT
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 2
Average target price 3,80 €
Spread / Average Target -14%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Christian Reinaudo President, Chief Executive Officer & Director
Julien de Wilde Chairman
Kris Hoornaert Chief Financial Officer
Jozef Cornu Non-Executive Director
Willy W. Duron Independent Non-Executive Director
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
AGFA-GEVAERT20.53%821
THERMO FISHER SCIENTIF..9.17%60 136
DANAHER CORPORATION10.50%59 629
BOSTON SCIENTIFIC CORP..12.44%33 160
PHILIPS1.72%29 605
INTUITIVE SURGICAL, IN..19.53%27 838
More Results